Items Tagged ‘Peter Noseworthy’
July 27, 2022
Big data dive confirms early intervention nets better outcomes for people with new onset AFib
Recent research led by Mayo Clinic showed the findings of the international clinical trial — Early Treatment of Atrial Fibrillation for Stroke Prevention Trial, or EAST‐AFNET 4 — are generalizable to routine clinical practice. The new findings are published online in the Journal of the American Heart Association. The original clinical trial included 2,789 patients […]
Tags: AFib, atrial fibrillation, big data, cardiovascular medicine, Center for the Science of Health Care Delivery, clinical trials, collaboration, Douglas Packer, EKG, electrocardiogram, health sciences research, Kern Health Care Delivery Scholars
June 3, 2022
Mayo Clinic research will be on display at the AcademyHealth Annual Research Meeting, June 4 – 7, in Washington, D.C. For people attending the conference, you are invited to stop by the booth, staffed by the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. In the double […]
Tags: Aaron Spaulding, AcademyHealth, Ahmed (Shafii) Mohamed, Alanna Chamberlain, artificial intelligence, Ben Pollock, Bridget Biggs, burnout, cardiovascular medicine, Center for the Science of Health Care Delivery, clinical trials, community engagement
September 28, 2021
By Advancing the Science contributor 
Andrew Limper, M.D., was the first named associate dean of Practice Transformation, in the Mayo Clinic Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. During his tenure with the center, and through his leadership, Mayo Clinic streamlined practice transformative research and discovery efforts across the institution into a single, […]
Tags: Andrew Limper, artificial intelligence, basic science, Ben Pollock, biostatistics, cardiology, Center for Clinical and Translational Science, Center for the Science of Health Care Delivery, clinical trials, Curt Storlie, discovery research, electrocardiogram
May 11, 2021
Proving the value of a pre-K career development award program
For aspiring health care researcher leaders, a National Institutes of Health funded K-award may seem like the holy grail. These are externally-funded research career development awards that provide mentoring, funding and hands-on experience. Research experience and expertise is frequently a critical factor for future leadership within the institution. However, for some a K-award may not […]
Tags: Adam Schwartz, Ali Duarte Garcia, Amy Wang, Bjorg Thorsteinsdottir, Carrie Thompson, Cassie Kennedy, Center for the Science of Health Care Delivery, Christopher Russi, Christopher Shubert, Cristopher Destephano, Dorin Colibaseanu, Eleshia Morrison
April 5, 2021
Mayo Clinic Research in the news — 4/5/2021
Mayo Clinic research and faculty experts were featured in a variety of news stories including 3D printed surgical models, early treatment for smoldering multiple myeloma, and heart attacks in women. Updated guideline highlights new therapies, considerations in anaplastic thyroid cancer Healio, 4/1/2021 An updated guideline for best practices in managing anaplastic thyroid cancer stresses the […]
Tags: 3D printing, Alfredo Quinones-Hinojosa, Alzheimer's disease, artificial intelligence, blood cancer, chronic kidney disease, Clifford Jack Jr., COVID-19, digital health, Eric Moore, genetic testing, genetics
August 13, 2019
Inspired to innovate: Detecting heart disease earlier with the help of artificial intelligence
By Advancing the Science contributor
By Nicole Sisk Artificial intelligence will play a key role in Mayo Clinic’s future and that of health care worldwide. The Department of Cardiovascular Medicine is combining artificial intelligence with standard tests to improve patient care. Each year at Mayo Clinic, 250,000 patients have an electrocardiogram, or ECG. It’s a common, inexpensive test designed to […]
Tags: artificial intelligence, cardiology, cardiovascular medicine, Center for the Science of Health Care Delivery, diversity, health disparities, heart disease, Itzhak Zachi Attia, LaPrincess Brewer, Paul Friedman, Peter Noseworthy, Sharonne Hayes
August 5, 2019
Blood thinners in combination increase bleeding risk, Mayo study finds
Gastrointestinal bleeding is a common side effect for many blood-thinning medications. But new Mayo Clinic research finds that risk is amplified when patients receive more than one blood thinner – especially if they’re 75 or older. The study, published in Clinical Gastroenterology and Hepatology, found patients receiving an anticoagulant drug and an antiplatelet drug, in […]
Tags: AHRQ, anticoagulant, antiplatelet, blood thinner, Center for the Science of Health Care Delivery, Che Ngufor, gastroenterology, Neena Abraham, Nilay Shah, OptumLabs, Peter Noseworthy, Xiaoxi Yao
June 12, 2018
New collaboration to develop and test decisions for AFib patients
The Patient-Centered Outcomes Research Institute (PCORI) and American Heart Association (AHA) announced today that it is establishing AHA-PCORI Decision-making and Choices to Inform Dialogue and Empower AFib patients (DECIDE) Center. The DECIDE Center will be a collaboration between the University of Utah (where it will be based) and Mayo Clinic. The team has three projects: Identify […]
Tags: Center for the Science of Health Care Delivery, clinical trials, education, PCORI, Peter Noseworthy
May 3, 2018
Using new data to personalize stroke prevention
By Advancing the Science contributor
By Peter Noseworthy, MD, with Xiaoxi Yao, PhD, Mayo Clinic The irregular heartbeat known as atrial fibrillation (AF) is a common and serious heart disease impacting about 3 million Americans today. Patients with AF experience palpitations, shortness of breath and dizziness, which can make simple activities such as playing with grandchildren or walking upstairs challenging. […]
Tags: anticoagulant, atrial fibrillation, Center for the Science of Health Care Delivery, OptumLabs, Peter Noseworthy, Xiaoxi Yao
June 19, 2017
1 in 6 taking blood-thinning drugs may not be getting right dose, research shows
A growing number of Americans are expected to develop atrial fibrillation, a common heart condition characterized by an irregular and rapid heart rate. But almost 1 in 6 of the millions of Americans on new blood-thinning medications for a-fib may not be getting the right dose, Mayo Clinic research finds.
Tags: anticoagulant, atrial fibrillation, Center for the Science of Health Care Delivery, kidney disease, OptumLabs, Peter Noseworthy, stroke, Xiaoxi Yao